GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care
SAN JOSE, Calif.–(BUSINESS WIRE)–GNQ Insilico, Inc. (GNQ), a precision medicine TechBio company, today announced a collaboration with IBM…